Seroprevalence of chikungunya and o'nyong-nyong viruses in Senegal, West Africa

Prince Baffour Tonto,Mouhamad Sy,Ibrahima Mbaye Ndiaye,Mariama Toure,Amy Gaye,Mariama Aidara,Amadou Moctar Mbaye,Abdoulaye Kane Dia,Mamadou Alpha Diallo,Jules Francois Gomis,Mamadou Samba Yade,Younous Diedhiou,Baba Dieye,Khadim Diongue,Mame Cheikh Seck,Aida S. Badiane,Bobby Brooke Herrera,Daouda Ndiaye
DOI: https://doi.org/10.1101/2024.09.06.24313176
2024-12-22
Abstract:Background Arthritogenic alphaviruses such as chikungunya (CHIKV) and onyong-nyong (ONNV) viruses have shown capacity to cause widespread epidemics, with recurrent and sporadic outbreaks occurring throughout sub-Saharan Africa. Methods We analyzed the seroprevalence for CHIKV and ONNV in 470 non-febrile subjects from three regions in Senegal (Sindia, 2018; Thies, 2018; and Kedougou, 2022/2023) using retrospective samples. We assessed the presence of anti-CHIKV IgG and neutralizing antibody titers against CHIKV and ONNV via enzyme-linked immunosorbent assay (ELISA) and microneutralization tests, respectively, and determined risk factors of CHIKV and ONNV exposure by binary logistic regression. Results The overall alphavirus seroprevalence based on an anti-CHIKV viral like particle (VLP) IgG ELISA was 38.5%, with rates varying geographically: Kedougou (48.6%), Thies (31.9%), and Sindia (14.9%). Neutralizing antibody titers revealed CHIKV and ONNV seroprevalence rates of 7.4% and 9.8%, respectively, with significant variations by region and age group. Cross-reactivity analysis showed that 82.9% of CHIKV cases exhibited a neutralizing response to ONNV, while 71.7% of ONNV cases cross-neutralized CHIKV. Residents of Thies had significantly higher odds of CHIKV infection (aOR, 3.147; 95% CI: 1.164-8.510) while ONNV infection was more likely in Kedougou (aOR, 3.888; 95% CI: 1.319-11.466). Furthermore, older age (> 40 years) was a significant risk factor both CHIKV (aOR, 2.094; 95% CI: 0.846-5.185) and ONNV infection (aOR, 2.745; 95% CI: 1.212-6.216). Conclusions Our study confirms the co-circulation of CHIKV and ONNV in Senegal, highlighting their geographic and demographic distribution. These findings underscore the need for continued surveillance, alphavirus testing, and tailored public health strategies to mitigate their impact in Senegal.
What problem does this paper attempt to address?